about
Decoding the anticancer activity of VO-clioquinol compound: the mechanism of action and cell death pathways in human osteosarcoma cells.In vitro and in vivo antitumor effects of the VO-chrysin complex on a new three-dimensional osteosarcoma spheroids model and a xenograft tumor in mice.Deciphering the effect of an oxovanadium(iv) complex with the flavonoid chrysin (VOChrys) on intracellular cell signalling pathways in an osteosarcoma cell line.Oxidovanadium(IV) complexes with chrysin and silibinin: anticancer activity and mechanisms of action in a human colon adenocarcinoma model.Polyoxometalates as antitumor agents: Bioactivity of a new polyoxometalate with copper on a human osteosarcoma model.Vanadium, Ruthenium and Copper Compounds: A New Class of Nonplatinum Metallodrugs with Anticancer Activity.Synthesis and characterization of CaCO3-biopolymer hybrid nanoporous microparticles for controlled release of doxorubicin.Antiproliferative and apoptosis-inducing activity of an oxidovanadium(IV) complex with the flavonoid silibinin against osteosarcoma cells.Vanadium and cancer treatment: antitumoral mechanisms of three oxidovanadium(IV) complexes on a human osteosarcoma cell line.Antitumor properties of a vanadyl(IV) complex with the flavonoid chrysin [VO(chrysin)2EtOH]2 in a human osteosarcoma model: the role of oxidative stress and apoptosis.Cu(Nor)2·5H2O, a complex of Cu(II) with Norfloxacin: theoretic approach and biological studies. Cytotoxicity and genotoxicity in cell cultures.Hydroxylamido-amino acid complexes of oxovanadium(V). Toxicological study in cell culture and in a zebrafish model.Copper(II) Complexes with Saccharinate and Glutamine as Antitumor Agents: Cytoand Genotoxicity in Human Osteosarcoma Cells.Comparative antitumor studies of organoruthenium complexes with 8-hydroxyquinolines on 2D and 3D cell models of bone, lung and breast cancerIn vitro and in vivo anticancer effects of two quinoline-platinum(II) complexes on human osteosarcoma models
P50
Q38701263-CD5D95EF-4989-4284-ADF9-ADFD2E61C607Q38742783-660D2046-F7D5-4A5A-B101-F0F8299E4C69Q38771349-903780E4-D945-4B04-A40A-54818B4220FDQ38832743-ACAD2985-F71F-487B-8516-D07F3DD74E1BQ38934582-19E5057B-BEFC-40B5-BF77-D4EC7AEE7F8BQ38935554-A92A7AE4-F584-4D9F-9319-3BA6DF903E19Q38953048-237D484A-6D11-4C5D-B54A-C9036CE85C5AQ39063063-0E97B33D-587E-4616-B695-5C4FACE31BBAQ39066315-84E06A6D-FC96-4762-B1A9-675002CA0901Q39140333-21D2F4F2-2F2A-42CE-BDD3-416566379BD7Q39226440-A1D77508-F11E-46BA-9471-9D9760C4F638Q39257926-B0EFA6CB-2EEC-46D6-BE0F-9D781C566445Q46549071-653029D8-6F48-43AC-94F4-46098FCD86E5Q64033078-6DF0982D-E0B6-452A-83BC-E6A22CB243B6Q91126170-D77000D9-270B-4EE9-A9FD-5B6F19286C37
P50
description
researcher ORCID ID = 0000-0003-1010-3997
@en
wetenschapper
@nl
name
Ignacio León
@ast
Ignacio León
@en
Ignacio León
@es
Ignacio León
@nl
type
label
Ignacio León
@ast
Ignacio León
@en
Ignacio León
@es
Ignacio León
@nl
prefLabel
Ignacio León
@ast
Ignacio León
@en
Ignacio León
@es
Ignacio León
@nl
P1153
54889851200
P21
P31
P496
0000-0003-1010-3997